381 related articles for article (PubMed ID: 26189059)
21. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
[TBL] [Abstract][Full Text] [Related]
22. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
[TBL] [Abstract][Full Text] [Related]
23. WT1 regulates angiogenesis in Ewing Sarcoma.
Katuri V; Gerber S; Qiu X; McCarty G; Goldstein SD; Hammers H; Montgomery E; Chen AR; Loeb DM
Oncotarget; 2014 May; 5(9):2436-49. PubMed ID: 24810959
[TBL] [Abstract][Full Text] [Related]
24. Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo.
Yao N; Ren K; Jiang C; Gao M; Huang D; Lu X; Lou B; Peng F; Yang A; Wang X; Ni Y; Zhang J
Tumour Biol; 2015 Nov; 36(11):8499-510. PubMed ID: 26026583
[TBL] [Abstract][Full Text] [Related]
25. Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers.
Morales-Guadarrama G; García-Becerra R; Méndez-Pérez EA; García-Quiroz J; Avila E; Díaz L
Cells; 2021 Jul; 10(7):. PubMed ID: 34359928
[TBL] [Abstract][Full Text] [Related]
26. Role of Bcl-2 and its associated miRNAs in vasculogenic mimicry of hepatocellular carcinoma.
Zhao N; Sun BC; Zhao XL; Wang Y; Meng J; Che N; Dong XY; Gu Q
Int J Clin Exp Pathol; 2015; 8(12):15759-68. PubMed ID: 26884845
[TBL] [Abstract][Full Text] [Related]
27. Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry.
Ren K; Zhang J; Gu X; Wu S; Shi X; Ni Y; Chen Y; Lu J; Gao Z; Wang C; Yao N
Exp Cell Res; 2018 Aug; 369(1):80-89. PubMed ID: 29750896
[TBL] [Abstract][Full Text] [Related]
28. Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231.
Xu MR; Wei PF; Suo MZ; Hu Y; Ding W; Su L; Zhu YD; Song WJ; Tang GH; Zhang M; Li P
Biomed Res Int; 2019; 2019():6543230. PubMed ID: 30723742
[TBL] [Abstract][Full Text] [Related]
29. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
30. Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway.
Gong W; Sun B; Zhao X; Zhang D; Sun J; Liu T; Gu Q; Dong X; Liu F; Wang Y; Lin X; Li Y
Oncotarget; 2016 Oct; 7(43):70152-70167. PubMed ID: 27659524
[TBL] [Abstract][Full Text] [Related]
31. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC
Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372
[TBL] [Abstract][Full Text] [Related]
32. Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
Orecchia P; Conte R; Balza E; Pietra G; Mingari MC; Carnemolla B
Oncotarget; 2015 Nov; 6(35):37426-42. PubMed ID: 26460958
[TBL] [Abstract][Full Text] [Related]
33. Tumor cell vascular mimicry: Novel targeting opportunity in melanoma.
Hendrix MJ; Seftor EA; Seftor RE; Chao JT; Chien DS; Chu YW
Pharmacol Ther; 2016 Mar; 159():83-92. PubMed ID: 26808163
[TBL] [Abstract][Full Text] [Related]
34. Signaling pathways in tumor vasculogenic mimicry.
Vartanian AA
Biochemistry (Mosc); 2012 Sep; 77(9):1044-55. PubMed ID: 23157265
[TBL] [Abstract][Full Text] [Related]
35. Leptin Promotes Vasculogenic Mimicry in Breast Cancer Cells by Regulating Aquaporin-1.
Han DS; Lee EO
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791252
[TBL] [Abstract][Full Text] [Related]
36. VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro.
Mei J; Gao Y; Zhang L; Cai X; Qian Z; Huang H; Huang W
Exp Oncol; 2008 Mar; 30(1):29-34. PubMed ID: 18438338
[TBL] [Abstract][Full Text] [Related]
37. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
38. CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer.
Liu TJ; Sun BC; Zhao XL; Zhao XM; Sun T; Gu Q; Yao Z; Dong XY; Zhao N; Liu N
Oncogene; 2013 Jan; 32(5):544-53. PubMed ID: 22469978
[TBL] [Abstract][Full Text] [Related]
39. The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma.
von Heyking K; Roth L; Ertl M; Schmidt O; Calzada-Wack J; Neff F; Lawlor ER; Burdach S; Richter GH
Oncotarget; 2016 Jul; 7(27):41767-41780. PubMed ID: 27363011
[TBL] [Abstract][Full Text] [Related]
40. CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.
Gao Y; Feng Y; Shen JK; Lin M; Choy E; Cote GM; Harmon DC; Mankin HJ; Hornicek FJ; Duan Z
Sci Rep; 2015 Jun; 5():11365. PubMed ID: 26079799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
